Key Takeaways
- Knee osteoarthritis is not simply “wear and tear.” It is a whole-joint disease involving cartilage, bone, synovium, menisci, ligaments and surrounding muscles.
- X-ray severity and symptom severity do not always match. Treatment decisions should be based on pain, stiffness, function, examination, patient goals and the overall clinical picture, not an X-ray grade alone.
- Exercise, education and weight management where appropriate are core treatments. Medicines and injections can be useful for selected patients, but they do not reverse established osteoarthritis.
- Arthroscopic washout or debridement is not recommended as routine treatment for osteoarthritis.
- Knee replacement is generally considered when symptoms substantially impair quality of life and appropriate non-surgical treatment has become ineffective or unsuitable.
- Once a patient with moderate-to-severe symptomatic osteoarthritis has already failed appropriate nonoperative treatment and has a sound indication for arthroplasty, repeatedly delaying surgery simply to repeat the same treatments is not supported by current guidance.
- The decision to proceed to knee replacement should be individualized and shared. Age, body weight or an X-ray grade alone should not be used as automatic yes-or-no rules.
Introduction
Advanced bilateral knee osteoarthritis on AP and lateral radiographs, demonstrating marked degenerative changes.
Knee arthritis is one of the most common reasons adults develop persistent knee pain, stiffness and loss of mobility. Yet the phrase “arthritis” is often used too loosely. A patient may be told that an X-ray shows arthritis and assume that surgery is inevitable, while another patient with advanced structural changes may continue functioning reasonably well with non-surgical treatment (American Academy of Orthopaedic Surgeons [AAOS], 2021; National Institute for Health and Care Excellence [NICE], 2022).
Both interpretations can be misleading.
Osteoarthritis is better understood as a disease of the whole joint rather than the simple wearing away of a single layer of cartilage. Cartilage loss is important, but changes also occur in subchondral bone, synovium, menisci, ligaments and periarticular muscles. Symptoms can fluctuate, and structural progression does not occur at the same speed in every person.
The practical question is therefore not, “How bad does the X-ray look?” It is, “How much is the disease affecting this person, which treatments remain reasonable, and at what point does the balance shift toward joint replacement?”
What Causes Knee Osteoarthritis?
Earlier/milder radiographic knee osteoarthritis, illustrating the spectrum of structural disease.
There is usually no single cause. Risk reflects a combination of age, genetics, previous injury, joint shape and alignment, muscle function, body weight, occupational or repetitive loading, and metabolic or inflammatory influences.
Previous major knee injuries can increase later osteoarthritis risk, particularly when the meniscus, articular cartilage or stabilising ligaments have been damaged. Malalignment may concentrate load on one compartment of the knee. Obesity can increase mechanical loading and is also associated with systemic metabolic factors that may influence osteoarthritis biology.
However, osteoarthritis should not be interpreted as proof that a patient has “used the knee too much.” Normal physical activity is not the enemy. In fact, therapeutic exercise is a central part of evidence-based management.
Symptoms and Diagnosis
Typical symptoms include activity-related pain, stiffness, difficulty with stairs or prolonged walking, reduced range of motion, swelling, crepitus and declining confidence in the knee. Some patients develop varus or valgus deformity as disease progresses.
In a typical patient aged 45 or older with activity-related joint pain and either no morning stiffness or morning stiffness lasting no more than about 30 minutes, osteoarthritis can often be diagnosed clinically. NICE specifically advises that imaging is not routinely required to make the diagnosis when the presentation is typical (NICE, 2022).
Imaging becomes useful when the diagnosis is uncertain, symptoms are atypical, another disorder is suspected, or surgery is being considered and the anatomy needs to be defined.
Plain weight-bearing radiographs remain useful for assessing joint-space narrowing, osteophytes, subchondral sclerosis, deformity and compartment involvement. MRI is not routinely necessary for straightforward established osteoarthritis and should be requested only when it is likely to change management.
WHAT DO THE “STAGES” OF KNEE ARTHRITIS MEAN?
Radiographic osteoarthritis is often described using the Kellgren-Lawrence system, from grade 0 to grade 4. Broadly, the scale progresses from no definite radiographic osteoarthritis to increasingly definite osteophytes, joint-space narrowing, sclerosis and bony deformity.
This staging is useful for describing structural severity in research and clinical communication, but it must not become a surgical rule.
A patient with a severe-looking X-ray may have manageable symptoms. Another patient with less dramatic radiographic change may have substantial disability because of pain, synovitis, weakness, loss of motion or other factors. Modern guidelines therefore emphasize symptoms and physical function rather than numerical severity scores alone when considering referral for joint replacement.
The First Line of Treatment: Education, Exercise and Weight Management
The most consistently supported non-surgical treatments are not technological. They are education, therapeutic exercise and, for patients living with overweight or obesity, weight management (American Academy of Orthopaedic Surgeons [AAOS], 2021; National Institute for Health and Care Excellence [NICE], 2022).
Exercise
Exercise should be tailored to the individual and can include quadriceps and hip strengthening, range-of-motion work, aerobic activity and functional training. Some discomfort when beginning exercise is common and does not automatically mean the joint is being damaged. Regular adherence is more important than finding one “perfect” exercise.
Weight Management
For patients with overweight or obesity, weight reduction can improve pain and physical function. NICE advises that any amount of weight loss is likely to help and that a larger reduction, such as around 10% of body weight, may provide greater benefit than a smaller reduction (NICE, 2022).
A walking stick or other aid can also be useful when it meaningfully improves mobility and confidence.
Medications: Useful, but Not a Cure
Medication should support function and exercise rather than replace them.
For knee osteoarthritis, topical non-steroidal anti-inflammatory drugs are recommended by NICE as an initial pharmacological option. Oral NSAIDs may be considered when topical treatment is inadequate or unsuitable, but gastrointestinal, renal, cardiovascular and medication-related risks must be considered (NICE, 2022; AAOS, 2021; Brophy & Fillingham, 2022).
Long-term opioid treatment is not a good strategy for routine osteoarthritis management. NICE advises against strong opioids for osteoarthritis and does not recommend routine paracetamol or weak opioids except in selected short-term situations when other options are unsuitable or ineffective (NICE, 2022).
No tablet has been shown to reliably regenerate advanced articular cartilage or reverse established structural osteoarthritis.
What About Injections?
Injections are often discussed as if they form a simple ladder before surgery, but different products have different evidence bases.
Corticosteroid Injections
Intra-articular corticosteroid injections can provide short-term symptom relief in selected patients. NICE describes the expected benefit as short-term, approximately two to ten weeks, and suggests considering corticosteroid injection when other pharmacological treatments are ineffective or unsuitable, or when a temporary reduction in pain may help a patient participate in exercise (NICE, 2022).
Hyaluronic Acid
Hyaluronic acid remains controversial. Recommendations differ among professional organisations, but NICE advises against offering intra-articular hyaluronan for osteoarthritis (NICE, 2022).
Platelet-Rich Plasma and Orthobiologic Preparations
Platelet-rich plasma (PRP) and other orthobiologic treatments remain areas of active research. Some studies have reported improvements in pain and function among selected patients with mild-to-moderate osteoarthritis.
However, interpreting these studies is challenging because PRP preparations differ substantially. Researchers use different platelet concentrations, activation methods, injection protocols and comparison treatments. As a result, outcomes have been inconsistent.
Current evidence does not support describing PRP as a proven cartilage-regeneration therapy. Patients considering these treatments should discuss the expected benefits, costs, uncertainties and alternatives with their physician.
When Arthroscopy Does Not Help
A common misconception is that an arthroscope can simply “clean out” an arthritic knee.
For established osteoarthritis, routine arthroscopic lavage or debridement is not recommended. NICE specifically advises against it for osteoarthritis. Arthroscopy may still have a role for separate, clearly defined mechanical pathology in selected circumstances, but degenerative meniscal changes seen on MRI are common in arthritic knees and do not automatically create an indication for surgery (NICE, 2022).
When Should Knee Replacement Enter the Discussion?
Postoperative long-leg radiograph following total knee replacement, illustrating limb-alignment assessment.
Knee replacement should not be recommended because a patient reaches a particular birthday, BMI, X-ray grade or pain score.
NICE recommends considering referral for joint replacement when joint symptoms such as pain, stiffness, reduced function or progressive deformity are substantially affecting quality of life and non-surgical management has become ineffective or unsuitable. It also recommends using clinical assessment rather than numerical scoring systems to decide who should be referred (NICE, 2022).
In practical terms, several features usually come together:
- Persistent pain despite an appropriate treatment programme
- Difficulty walking, climbing stairs, working, sleeping or performing daily activities
- Progressive loss of motion or deformity
- Radiographic osteoarthritis that reasonably explains the symptoms
- Declining benefit from reasonable non-surgical options
- A patient who understands the likely benefits, limitations, risks and rehabilitation requirements of surgery
The final decision should come from the combination, not from any one item.
Should Every Non-Surgical Treatment Be Repeated Before Surgery?
No.
This is an important area in which contemporary guidance has become more explicit. The 2023 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline addressed patients with symptomatic moderate-to-severe osteoarthritis who had already failed nonoperative therapy and had been appropriately indicated for total hip or knee arthroplasty (American College of Rheumatology & American Association of Hip and Knee Surgeons [ACR/AAHKS], 2023).
Its conditional recommendation was to proceed to surgery without mandatory delay simply to try additional physical therapy, gait aids, anti-inflammatory medicines or injections. The panel found no evidence that such delay improves outcomes once the patient has already crossed the threshold for arthroplasty (ACR/AAHKS, 2023).
That does not mean medical optimisation should be ignored. The same guideline highlights situations in which postponement can be reasonable, including efforts to reduce or stop nicotine use and to improve poorly controlled diabetes (ACR/AAHKS, 2023).
The principle is straightforward: optimisation should address modifiable surgical risk, not become an endless requirement to repeat treatments that have already failed.
Age, Weight and Comorbidity: Risk Factors Are Not Automatic Exclusions
Age, obesity and medical conditions can influence operative risk and recovery, but they should be discussed in terms of individualized risk rather than used as crude exclusion rules.
NICE specifically advises not excluding a person from referral for joint replacement solely because of age, sex or gender, smoking, comorbidities, or overweight/obesity based on BMI. Instead, clinicians should explain how these factors may alter risk and work with the patient to optimize modifiable problems where feasible (NICE, 2022).
This distinction matters.
“You have a risk factor” is not the same as “you can never have surgery.”
Postoperative AP radiograph following total knee replacement, illustrating implant position.
Total or Partial Knee Replacement?
Not every arthritic knee requires replacement of every compartment.
Total Knee Replacement
Total knee replacement resurfaces the femoral and tibial joint surfaces across the knee and is the most common option for multi-compartment disease.
Partial (Unicompartmental) Knee Replacement
Partial, or unicompartmental, knee replacement may be appropriate when arthritis is truly confined to one compartment and the remaining knee anatomy, ligaments and symptoms satisfy appropriate selection criteria.
The choice depends on disease distribution, ligament function, deformity, bone quality, surgeon assessment and patient-specific goals. It should not be decided by marketing preference alone.
Where Does Robotic Technology Fit?
Robotic assistance becomes relevant only after the diagnosis and indication for surgery are established.
It can assist with patient-specific planning, measurements, alignment assessment and execution of bone preparation. It may improve the reproducibility of achieving the intended plan, but it does not determine whether a patient actually needs knee replacement and it cannot substitute for patient selection, surgical judgement, tissue handling, complication prevention or rehabilitation.
Similarly, the surgical approach is a separate decision.
A muscle-sparing or mini-subvastus approach concerns how the surgeon exposes the knee and handles the extensor mechanism.
Robotic assistance concerns planning and execution.
They can be used together, but they should not be conflated.
What Patients Should Ask Before Agreeing to Surgery
A useful consultation should answer several questions clearly:
- Are my symptoms actually coming from knee osteoarthritis?
- Which reasonable non-surgical treatments have I tried, and what benefit remains possible from them?
- How much is the knee affecting my daily life and function?
- Does my examination and imaging support the diagnosis and proposed operation?
- Is total or partial replacement more appropriate, and why?
- What health factors should be optimized before surgery?
- What improvement is realistic for pain, walking, stairs, work and recreation?
- What cannot be guaranteed?
- What will my rehabilitation involve?
- If robotic assistance is proposed, what specific part of the operation will it assist?
Final Thoughts
Knee osteoarthritis is not a race toward surgery. Many patients can manage symptoms for years with education, exercise, weight management, appropriate medication and selective injections.
But non-surgical treatment should not become an indefinite obstacle when severe symptoms continue to limit quality of life and the clinical indication for joint replacement is clear.
The most defensible approach is staged and individualized.
Treat the patient, not the X-ray.
Use non-surgical care when it is likely to help.
Optimize modifiable risk before surgery.
Discuss replacement when symptoms, function, examination, imaging and previous treatment point in the same direction.
Use technology only after the fundamental decision has been made correctly.
Frequently Asked Questions
Does grade 4 arthritis always require knee replacement?
No. Grade 4 describes severe radiographic change, but surgery should be based on symptoms, function, examination, treatment history and patient goals as well as imaging.
Can exercise make knee arthritis worse?
Appropriately prescribed therapeutic exercise is a core treatment for osteoarthritis. Some temporary discomfort can occur when exercise begins, but regular exercise generally improves pain and function.
Can weight loss help knee arthritis?
Yes, particularly for people living with overweight or obesity. Even modest weight loss can help, and larger sustainable reductions may provide greater symptomatic and functional benefit.
Do injections rebuild cartilage?
Current injections should not be described as proven methods for rebuilding advanced lost cartilage. Some may reduce symptoms for a period of time in selected patients.
Should I have an MRI before deciding about knee replacement?
Not routinely. Weight-bearing radiographs and clinical assessment are usually sufficient for established osteoarthritis. MRI is useful when another diagnosis is suspected or when it would change management.
Is arthroscopy a treatment for arthritis?
Routine arthroscopic washout or debridement is not recommended for osteoarthritis.
When is it reasonable to stop repeating conservative treatment?
When moderate-to-severe symptomatic osteoarthritis continues to substantially impair quality of life despite appropriate nonoperative treatment and the patient has a sound indication for arthroplasty, current ACR/AAHKS guidance does not support mandatory delay simply to repeat additional physical therapy, NSAIDs, gait aids or injections (ACR/AAHKS, 2023).
Does being overweight automatically disqualify someone from knee replacement?
No. Weight can influence risk and should be discussed and optimized where possible, but NICE advises against excluding patients from referral solely on BMI (NICE, 2022).
Does robotic surgery decide whether I need a knee replacement?
No. The indication for surgery is a clinical decision. Robotic technology can assist planning and execution after the decision to operate has been made.
References
American Academy of Orthopaedic Surgeons. (2021). Management of osteoarthritis of the knee (non-arthroplasty), third edition: Evidence-based clinical practice guideline. https://www.aaos.org/quality/quality-programs/osteoarthritis-of-the-knee/
Brophy, R. H., & Fillingham, Y. A. (2022). AAOS clinical practice guideline summary: Management of osteoarthritis of the knee (nonarthroplasty), third edition. Journal of the American Academy of Orthopaedic Surgeons, 30(9), e721–e729. https://doi.org/10.5435/JAAOS-D-21-01233
American College of Rheumatology, & American Association of Hip and Knee Surgeons. (2023). 2023 ACR/AAHKS clinical practice guideline for the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy is ineffective. https://rheumatology.org/indications-for-total-hip-and-knee-arthroplasty-guideline
National Institute for Health and Care Excellence. (2022). Osteoarthritis in over 16s: Diagnosis and management (NICE guideline NG226). https://www.nice.org.uk/guidance/ng226
